Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia.

ABSTRACT:

SUBMITTER: Curik N 

PROVIDER: S-EPMC12463652 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature